CHFS vs. IRIX, PTHL, BSGM, NRXS, QTI, CUTR, STRR, NUWE, NDRA, and HSDT
Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include IRIDEX (IRIX), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), BioSig Technologies (BSGM), NeurAxis (NRXS), QT Imaging (QTI), Cutera (CUTR), Star Equity (STRR), Nuwellis (NUWE), ENDRA Life Sciences (NDRA), and Helius Medical Technologies (HSDT).
Nuwellis vs.
IRIDEX (NASDAQ:IRIX) and Nuwellis (NASDAQ:CHFS) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation, community ranking and earnings.
IRIDEX currently has a consensus price target of $2.00, suggesting a potential upside of 20.48%. Given IRIDEX's stronger consensus rating and higher probable upside, equities research analysts plainly believe IRIDEX is more favorable than Nuwellis.
In the previous week, IRIDEX had 1 more articles in the media than Nuwellis. MarketBeat recorded 1 mentions for IRIDEX and 0 mentions for Nuwellis. IRIDEX's average media sentiment score of 0.00 equaled Nuwellis'average media sentiment score.
20.1% of IRIDEX shares are held by institutional investors. Comparatively, 65.1% of Nuwellis shares are held by institutional investors. 7.3% of IRIDEX shares are held by company insiders. Comparatively, 0.6% of Nuwellis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
IRIDEX has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.
Nuwellis received 52 more outperform votes than IRIDEX when rated by MarketBeat users. Likewise, 69.53% of users gave Nuwellis an outperform vote while only 64.30% of users gave IRIDEX an outperform vote.
IRIDEX has higher revenue and earnings than Nuwellis. IRIDEX is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.
IRIDEX has a net margin of -22.79% compared to Nuwellis' net margin of -254.26%. Nuwellis' return on equity of -173.61% beat IRIDEX's return on equity.
Summary
IRIDEX beats Nuwellis on 9 of the 16 factors compared between the two stocks.
Get Nuwellis News Delivered to You Automatically
Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuwellis Competitors List
Related Companies and Tools
This page (NASDAQ:CHFS) was last updated on 1/22/2025 by MarketBeat.com Staff
Free CHFS Stock Alerts